This HTML5 document contains 189 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n8http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q54350050
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel vitenskapelig artikkel 2011年学术文章 article científic 2011年學術文章 2011年学术文章 artículo científico publicado en 2011 ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالهٔ علمی 2011년 논문 2011年学术文章 scienca artikolo наукова стаття, опублікована у вересні 2011 2011年学术文章 επιστημονικό άρθρο мақолаи илмӣ научни чланак scientific article videnskabelig artikel (udgivet 2011) научни чланак mokslinis straipsnis artikull shkencor 2011年學術文章 2011年學術文章 artigo científico (publicado na 2011) articol științific tudományos cikk мақолаи илмӣ מאמר מדעי научна статия vedecký článok articolo scientifico teaduslik artikkel wetenschappelijk artikel artigo científico article scientifique (publié 2011) 2011年學術文章 tieteellinen artikkeli บทความทางวิทยาศาสตร์ bilimsel makale vědecký článek სამეცნიერო სტატია 2011年學術文章 article scientific artículu científicu سائنسی مضمون artigo científico (publicado na 2011) գիտական հոդված 2011年の論文 bài báo khoa học 2011 nî lūn-bûn 2011年学术文章 vitskapeleg artikkel artykuł naukowy artikulong pang-agham naučni članak wissenschaftlicher Artikel مقالة علمية научная статья 2011年學術文章
p:P577
wds:Q54350050-245EAD06-481C-4046-9E27-B68D4CB99D63
wdt:P577
2011-09-08T00:00:00Z
p:P2888
wds:Q54350050-5B761794-DC1A-47EE-8004-7864E3A72EC9
wdt:P2888
n11:s00280-011-1730-9
p:P2860
wds:Q54350050-6C242F8A-8E72-4491-9D53-6731B8998154 wds:Q54350050-724329AD-5A6D-4F30-8636-405C2350EF15 wds:Q54350050-74EA4425-C04B-4F2F-BB04-78557D84E86E wds:Q54350050-84D54CE9-590B-41F0-B301-87771775AF30 wds:Q54350050-64F0B9D1-E99F-4E72-AE68-02F71B861822 wds:Q54350050-66520FB2-B290-4854-BAA2-FC9F75050721 wds:Q54350050-6B9746DD-6A7A-4E7A-87E2-71D9534D9703 wds:Q54350050-BA11915D-60C1-4F9B-9A68-661992A15CE7 wds:Q54350050-BFB80595-4DC0-4AD0-BA4B-EDFA7718CD29 wds:Q54350050-BFC4A399-9F77-4738-BE8F-D867644BAF38 wds:Q54350050-CF4173CD-0AA5-422F-9C22-9018302CA50B wds:Q54350050-EA84FBD1-E6C4-4E5D-B63E-D63078F551AA wds:Q54350050-8EECE9DB-08FD-46F1-A5E7-8624305AD79E wds:Q54350050-980400EE-FEA2-4D41-9D7F-F77BADC13A96 wds:Q54350050-07BFC3CB-E30D-4E5F-B35B-02E8171340BA wds:Q54350050-0916345D-DDA7-47CE-B38D-1949737174F0 wds:Q54350050-098DDFEF-3734-470D-91CC-E63C0BDDAE8E wds:Q54350050-0E6A7FF0-8072-4C27-A061-B759FB133231 wds:Q54350050-215A49E2-627C-4660-8B77-CF2C9EAF2D63 wds:Q54350050-06DDF477-354A-473B-9D0C-C66CD1A9093B wds:Q54350050-400AB09A-2B2E-45F8-80FE-C2C316583AB7 wds:Q54350050-4057234F-423D-4693-9341-7986856E1C61 wds:Q54350050-5A8D2323-4538-4471-B0A4-E2C67C480ED8 wds:Q54350050-266983F2-6F75-40D4-851D-B13F23DFEA17 wds:Q54350050-2B894329-5105-493C-8DC5-34589897B4BE wds:Q54350050-2CD25C43-8994-4F32-AD4F-C5F5A4A2254E
wdt:P2860
wd:Q29618675 wd:Q37581289 wd:Q29617404 wd:Q44362100 wd:Q34315684 wd:Q57578575 wd:Q37686055 wd:Q42507441 wd:Q43138098 wd:Q34162335 wd:Q42482998 wd:Q42466578 wd:Q35007222 wd:Q30959521 wd:Q46691182 wd:Q28271274 wd:Q30494798 wd:Q46771645 wd:Q42519924 wd:Q37198196 wd:Q38411969 wd:Q38420708 wd:Q42505075 wd:Q42511189 wd:Q54383848 wd:Q37406658
p:P2093
wds:Q54350050-F084BC71-F2EB-4463-81FC-7DA55F4F5226 wds:Q54350050-43FA6610-8603-4003-BEBA-B2FB49929E35 wds:Q54350050-4768D9B5-F119-4322-91FC-98949CF0A512 wds:Q54350050-3BB59F3C-3288-4CB3-8410-EC871FBF9FC2 wds:Q54350050-3478BDFA-C8CC-40EA-B82F-9E093475FFC5 wds:Q54350050-2852C0E6-4A43-42B6-9BE6-1133CFBE4712 wds:Q54350050-18A829AC-2BCF-4BE4-BD72-7DE8D6156C0C wds:Q54350050-0AE83110-DA8E-42F2-A487-613E4D2FAC7F wds:Q54350050-011BC3D6-B756-496F-9B24-941B35BB37E7 wds:Q54350050-F04896E0-7778-4EDE-93D1-7DB5493D3411 wds:Q54350050-AE88DA93-006B-416D-848A-2B4D3099657A wds:Q54350050-A1E2B23A-507A-4BB8-B352-B11EEF87F4CD wds:Q54350050-AE661238-20FE-4A07-AD61-1FD59E9503AF wds:Q54350050-9ACA9960-1C6D-4783-BDC0-6BCE41B62FA1 wds:Q54350050-8F84D2AF-1E3B-4D97-B5CD-26F3580249DF wds:Q54350050-92C504B3-276C-4D02-8022-C782CA3E4772 wds:Q54350050-8721814C-2F36-438A-B49B-E75624EABB5C wds:Q54350050-70070E35-18C7-41DF-A5F9-B131C6B084E4 wds:Q54350050-5C3753BB-4E28-4A19-AD15-3855C60B6596 wds:Q54350050-60A601BE-2C94-498C-9043-BC79F211C0E4 wds:Q54350050-5B0A9999-2DA9-46AC-925E-FB4829FC7C66
wdt:P2093
P Arapantoni O Tzaida I Kostopoulos R M Wirtz C A Papadimitriou H Gogas N Pavlidis R Kronenwett C Valavanis C Christodoulou K T Kalogeras I Papaspirou D Pectasides A Batistatou D Televantou A G Eleftheraki P Skarlos E Timotheadou D V Skarlos G Aravantinos E Koutselini
rdfs:label
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group
skos:prefLabel
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri
schema:name
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri
p:P50
wds:Q54350050-F7A0C680-E6B1-4D7F-9F78-1093DB6B1916 wds:Q54350050-35DD0686-FD2C-45B2-8E6D-778FDDF827F0
wdt:P50
wd:Q56432880 wd:Q41163950
p:P1476
wds:Q54350050-42561A89-AA81-478D-93C2-8A623B1D5802
wdt:P1476
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri
p:P304
wds:Q54350050-6E8F8B16-4380-4113-824A-0C481E47F302
wdt:P304
533-546
p:P31
wds:Q54350050-61FE9033-F0C2-4F1E-A8E4-2B8E74ED592E
wdt:P31
wd:Q13442814
p:P921
wds:Q54350050-7B6928E4-2CAE-4588-B213-7A90E8A9C897
wdt:P921
wd:Q974135
p:P698
wds:Q54350050-DB34CA83-DC4C-4722-8C84-B8F764B818E1
wdtn:P698
n13:21901395
wdt:P698
21901395
p:P1433
wds:Q54350050-1B2C8672-52E8-4104-AF3C-591860E58615
wdt:P1433
wd:Q326137
p:P433
wds:Q54350050-21663A59-DFAB-4FEE-A3E2-784FDC06E29E
p:P478
wds:Q54350050-5885EBFB-ED03-4F0F-97FC-3FACF6F22C7F
wdt:P433
2
wdt:P478
69
p:P356
wds:Q54350050-6E9201A9-3474-4255-B666-7CF222315B9D
wdtn:P356
n8:S00280-011-1730-9
wdt:P356
10.1007/S00280-011-1730-9